Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Clinical trial NCT00042796 · TERMINATED

Trial details

NCT number: NCT00042796
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Childhood Acute Myeloblastic Leukemia With Maturation (M2)Childhood Acute Promyelocytic Leukemia (M3)Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia

Start date: 2002-12-01
Primary completion: 2005-10-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.